Zero to Hero? Scope 3 Emissions – A Strategic Imperative for Pharma Companies Verena Ahnert Read more
Special Report Contract/Pharma Services Advancing Innovation and Global Reach: The Next Chapter in China’s Clinical Trial… November 12, 2025
Smart Chart Life Sciences & Pharma Radiotherapeutics on the Rise: Cracking the Supply Chain Code May 16, 2025
Case Study Life Sciences & Pharma Unlocking the Potential of Next-Generation PROTACs: A Strategic Roadmap for R&D Investment March 7, 2025 Our client engaged L.E.K. Consulting to develop a market overview across multiple key therapeutic areas (e.g., oncology, immunology, neuroscience) and…
Video / Webinar Healthcare Services Australia's Clinical Trials: Innovation and Growth February 24, 2025
Smart Chart Life Sciences & Pharma Look Forward 2025: Proving AI’s Value in Life Sciences January 22, 2025
